{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:31Z","timestamp":1787729431193,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/eja.0000000000000581","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T01:11:16Z","timestamp":1483060276000},"page":"288-296","source":"Crossref","is-referenced-by-count":13,"title":["Dipyrone (metamizole) markedly interferes with platelet inhibition by aspirin in patients with acute and chronic pain"],"prefix":"10.1097","volume":"34","author":[{"given":"Andrea","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Romann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kienbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Pavlakovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Werdehausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20200527","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","article-title":"Agranulocytosis associated with dipyrone (metamizol)","volume":"60","author":"Ibanez","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"R2-6-20200527","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1538-7836.2007.02800.x","article-title":"Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis","volume":"6","author":"Hohlfeld","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R3-6-20200527","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jacc.2013.07.039","article-title":"Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease","volume":"62","author":"Polzin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R4-6-20200527","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0038-1650627","article-title":"The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone","volume":"76","author":"Geisslinger","year":"1996","journal-title":"Thromb Haemostas"},{"key":"R5-6-20200527","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0014-2999(99)00477-X","article-title":"Regulation of cyclooxygenase activity by metamizol","volume":"378","author":"Campos","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R6-6-20200527","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1096\/fj.06-8061com","article-title":"Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic","volume":"21","author":"Hinz","year":"2007","journal-title":"FASEB J"},{"key":"R7-6-20200527","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2013.09.032","article-title":"Drug\/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets","volume":"721","author":"Saxena","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R8-6-20200527","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"R9-6-20200527","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH12-07-0532","article-title":"High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drug: pharmacological mechanisms and clinical relevance","volume":"109","author":"Hohlfeld","year":"2013","journal-title":"Thromb Haemost"},{"key":"R10-6-20200527","doi-asserted-by":"crossref","first-page":"e54309","DOI":"10.1371\/journal.pone.0054309","article-title":"Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patient: a nationwide study","volume":"8","author":"Olsen","year":"2013","journal-title":"PloS one"},{"key":"R11-6-20200527","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"R12-6-20200527","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00169246","article-title":"Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system","volume":"337","author":"Schror","year":"1988","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"R13-6-20200527","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Colleg Cardiol"},{"key":"R14-6-20200527","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/bmm.10.122","article-title":"Functional testing methods for the antiplatelet effects of aspirin","volume":"5","author":"Schr\u00f6r","year":"2011","journal-title":"Biomark Med"},{"key":"R15-6-20200527","first-page":"51","article-title":"Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers","volume":"6","author":"Nagelschmitz","year":"2014","journal-title":"Clin Pharmacol"},{"key":"R17-6-20200527","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00129784-200808050-00001","article-title":"Pharmacologic inhibition of platelet function: correlation between in vitro tests of platelet function and clinical outcomes","volume":"8","author":"Ashley","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"R18-6-20200527","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1160\/TH12-01-0026","article-title":"Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction","volume":"108","author":"Larsen","year":"2012","journal-title":"Thromb Haemost"},{"key":"R19-6-20200527","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjcard.2006.07.058","article-title":"Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction","volume":"99","author":"Valles","year":"2007","journal-title":"Am J Cardiol"},{"key":"R20-6-20200527","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCRESAHA.115.307016","article-title":"Platelet-mediated thrombosis: from bench to bedside","volume":"118","author":"Gurbel","year":"2016","journal-title":"Circ Res"},{"key":"R21-6-20200527","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","article-title":"Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study","volume":"125","author":"Reny","year":"2012","journal-title":"Circulation"},{"key":"R22-6-20200527","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/erc.12.144","article-title":"Identifying determinants of variability to tailor aspirin therapy","volume":"11","author":"Rocca","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R23-6-20200527","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ahj.2009.11.033","article-title":"Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to \u2018aspirin resistance\u2019","volume":"159","author":"Hennekens","year":"2010","journal-title":"Am Heart J"},{"key":"R24-6-20200527","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1755-5922.2010.00188.x","article-title":"Aspirin resistance and compliance with therapy","volume":"29","author":"Dawson","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"R25-6-20200527","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1160\/TH14-11-0922","article-title":"Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects","volume":"114","author":"Polzin","year":"2015","journal-title":"Thromb Haemost"},{"key":"R26-6-20200527","doi-asserted-by":"crossref","first-page":"14583","DOI":"10.1073\/pnas.251543298","article-title":"A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin","volume":"98","author":"Ouellet","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-6-20200527","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"Capone","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R28-6-20200527","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2007.11.054","article-title":"The antiplatelet effect of six nonsteroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers","volume":"101","author":"Gladding","year":"2008","journal-title":"Am J Cardiol"},{"key":"R29-6-20200527","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1388-1981(99)00105-5","article-title":"PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity","volume":"1440","author":"Rosenstock","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R30-6-20200527","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(02)02450-0","article-title":"On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1","volume":"453","author":"Burde","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R31-6-20200527","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1160\/TH07-01-0056","article-title":"Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings","volume":"97","author":"Crescente","year":"2007","journal-title":"Thromb Haemost"},{"key":"R32-6-20200527","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00003088-200847020-00006","article-title":"Population pharmacodynamic modelling of aspirin- and ibuprofen-induced inhibition of platelet aggregation in healthy subjects","volume":"47","author":"Hong","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R33-6-20200527","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejps.2008.10.015","article-title":"Kinetic modelling of NSAID action on COX-1: focus on in vitro\/in vivo aspects and drug combinations","volume":"36","author":"Goltsov","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"R34-6-20200527","first-page":"16","article-title":"Metamizol: Renaissance eines Analgetikums","volume":"151","author":"Reinhardt","year":"2006","journal-title":"Pharmazeutische Zeitung"},{"key":"R35-6-20200527","doi-asserted-by":"crossref","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","article-title":"Metamizole-associated adverse events: a systematic review and meta-analysis","volume":"10","author":"Kotter","year":"2015","journal-title":"PloS one"},{"key":"R36-6-20200527","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00702-013-1052-7","article-title":"Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone","volume":"120","author":"Elmas","year":"2013","journal-title":"J Neural Transm (Vienna"},{"key":"R37-6-20200527","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/FBP.0b013e3283584794","article-title":"Evaluation of the endogenous cannabinoid system in mediating the behavioral effects of dipyrone (metamizol) in mice","volume":"23","author":"Schlosburg","year":"2012","journal-title":"Behav Pharmacol"},{"key":"R38-6-20200527","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of nonsteroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"R39-6-20200527","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2013.11.019","article-title":"Monitoring of four dipyrone metabolites in communal wastewater by solid phase extraction liquid chromatography electrospray ionization quadrupole time-of-flight mass spectrometry","volume":"90","author":"Gyenge-Szabo","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"R40-6-20200527","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000000581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:44:43Z","timestamp":1620953083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003643-201705000-00006"}},"subtitle":["A case-control study"],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000000581","relation":{},"ISSN":["0265-0215"],"issn-type":[{"value":"0265-0215","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}